Grace M. Choong

713 total citations
21 papers, 467 citations indexed

About

Grace M. Choong is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Grace M. Choong has authored 21 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Grace M. Choong's work include Breast Cancer Treatment Studies (7 papers), Advanced Breast Cancer Therapies (5 papers) and Trace Elements in Health (3 papers). Grace M. Choong is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Advanced Breast Cancer Therapies (5 papers) and Trace Elements in Health (3 papers). Grace M. Choong collaborates with scholars based in United States, Canada and Switzerland. Grace M. Choong's co-authors include Douglas M. Templeton, Ying Liu, Ciara C. O’Sullivan, Grace Cullen, Matthew P. Goetz, James N. Ingle, Michael Keeney, Daniel W. Visscher, Zahraa Al‐Hilli and James W. Jakub and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CA A Cancer Journal for Clinicians.

In The Last Decade

Grace M. Choong

16 papers receiving 461 citations

Peers

Grace M. Choong
Janelle J. Bruinsma United States
Haobin Chen United States
Salmaan Quader United States
Yuyan Xu China
Xi Huang China
Harrison B. Solomon United States
Grace M. Choong
Citations per year, relative to Grace M. Choong Grace M. Choong (= 1×) peers Zhigang Zhuang

Countries citing papers authored by Grace M. Choong

Since Specialization
Citations

This map shows the geographic impact of Grace M. Choong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace M. Choong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace M. Choong more than expected).

Fields of papers citing papers by Grace M. Choong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace M. Choong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace M. Choong. The network helps show where Grace M. Choong may publish in the future.

Co-authorship network of co-authors of Grace M. Choong

This figure shows the co-authorship network connecting the top 25 collaborators of Grace M. Choong. A scholar is included among the top collaborators of Grace M. Choong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace M. Choong. Grace M. Choong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goetz, Matthew P., Grace M. Choong, Tanya L. Hoskin, et al.. (2025). Reply to: “Rethinking Treatment Priorities in Estrogen Receptor–Low Breast Cancer” and “CDK4/6 Inhibitors in Estrogen Receptor–Low Breast Cancer”. Journal of Clinical Oncology. 43(30). 3323–3324.
2.
Choong, Grace M., Tanya L. Hoskin, Judy C. Boughey, James N. Ingle, & Matthew P. Goetz. (2025). Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer. Journal of Clinical Oncology. 43(16). 1875–1885. 1 indexed citations
3.
Capasso, Ilaria, Camilla Nero, Marzia Del Re, et al.. (2025). Circulating tumor DNA in endometrial cancer: clinical significance and implications. International Journal of Gynecological Cancer. 35(4). 101656–101656. 3 indexed citations
4.
Hoskin, Tanya L., Michael Keeney, Grace M. Choong, et al.. (2025). Estrogen receptor expression in residual breast cancer following neoadjuvant chemotherapy.. Journal of Clinical Oncology. 43(16_suppl). 529–529. 1 indexed citations
5.
Choong, Grace M., Tanya L. Hoskin, Judy C. Boughey, James N. Ingle, & Matthew P. Goetz. (2024). The impact of adjuvant endocrine therapy (AET) omission in ER-low (1-10%) early-stage breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 513–513. 5 indexed citations
6.
Hendrickson, Andrea E. Wahner, Nathan R. Foster, Matthew S. Block, et al.. (2024). Phase II clinical trial of PLX038 in patients with platinum resistant ovarian, primary peritoneal and fallopian tube cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS5630–TPS5630. 1 indexed citations
7.
Santos, João M., Matthew S. Block, Johanna Mäenpää, et al.. (2024). PROTA: A phase I clinical trial combining an oncolytic adenovirus encoding for TNFa and IL-2 with pembrolizumab for the treatment of platinum-resistant or -refractory ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5562–5562.
8.
Jankú, Filip, Grace M. Choong, Mateusz Opyrchal, et al.. (2024). A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers. 16(6). 1137–1137. 10 indexed citations
9.
Budhathoki, Pravash, Anurag Adhikari, Grace M. Choong, et al.. (2023). Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast. Breast Cancer Research and Treatment. 200(2). 217–224. 7 indexed citations
10.
Choong, Grace M., Elizabeth Cathcart-Rake, Narjust Florez, et al.. (2023). Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. Journal of Cancer Education. 39(1). 58–64.
11.
Choong, Grace M., S. Liddell, Roberto A. Leon Ferre, et al.. (2022). Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study. Breast Cancer Research and Treatment. 196(1). 229–237. 9 indexed citations
12.
Dalvin, Lauren A., William J. Hogan, Mrinal M. Patnaik, et al.. (2021). Isolated T‐cell acute lymphoblastic leukemic optic disc infiltration. American Journal of Hematology. 96(12). 1717–1718.
13.
Choong, Grace M., Grace Cullen, & Ciara C. O’Sullivan. (2020). Evolving standards of care and new challenges in the management of HER2‐positive breast cancer. CA A Cancer Journal for Clinicians. 70(5). 355–374. 110 indexed citations
14.
Choong, Grace M., Roberto A. Leon‐Ferre, Ciara C. O’Sullivan, et al.. (2020). Abstract P1-19-42: Evaluation of mean corpuscular volume (MCV) as a pharmacodynamic predictive biomarker in patients receiving CDK4/6 inhibitors for metastatic breast cancer (MBC). Cancer Research. 80(4_Supplement). P1–19. 2 indexed citations
15.
16.
Al‐Hilli, Zahraa, Grace M. Choong, Michael Keeney, et al.. (2019). Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy. Breast Cancer Research and Treatment. 176(3). 709–716. 55 indexed citations
17.
Duma, Narjust, et al.. (2018). Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?. Current Oncology Reports. 20(8). 63–63. 3 indexed citations
18.
Choong, Grace M., Ying Liu, & Douglas M. Templeton. (2014). Interplay of calcium and cadmium in mediating cadmium toxicity. Chemico-Biological Interactions. 211. 54–65. 224 indexed citations
19.
Choong, Grace M., Ying Liu, & Douglas M. Templeton. (2013). Cadmium affects focal adhesion kinase (FAK) in mesangial cells: Involvement of CaMK‐II and the actin cytoskeleton. Journal of Cellular Biochemistry. 114(8). 1832–1842. 17 indexed citations
20.
Choong, Grace M., et al.. (2013). Cadmium-induced glutathionylation of actin occurs through a ROS-independent mechanism: Implications for cytoskeletal integrity. Toxicology and Applied Pharmacology. 272(2). 423–430. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026